Pharma cos, doctors embrace digital transformation to reconnect with each other virtually during pandemicOct 15, 2021
The doctor’s practice around diagnosing patients and prescribing pharmaceutical brands has also undergone a sea change because of the implementation of telemedicine guidelines.
The NPPO should aim to promote availability and accessibility to quality medicines.
IPC kickstarts skill development programme on Pharmacovigilance to address adverse events related to drugs, medical devicesOct 11, 2021
The skill development programme is a part of government’s ambitious Pradhan Mantri Kaushal Vikas Yojana to produce and nurture qualified pharmacovigilance personnel for effective PV.
Piramal Enterprises said its board has approved a composite scheme of arrangement providing for the demerger of its pharmaceuticals business and simplification of the corporate structure to create two listed entities in financial services and pharmaceuticals.
Experts recommend diagnostic, therapeutic interventions for malaria control and elimination in IndiaOct 07, 2021
To combat devastating effects of Malaria, the NMCP was launched in 1953 built around three key activities – insecticidal residual spray (IRS) with DDT; monitoring and surveillance of cases; and treatment of patients.
Prime Minister Narendra Modi said India can help in bringing the world out of the coronavirus crisis with mass vaccine distribution once all trials are completed successfully.
Collaborative partnerships are of increasing importance for successful innovation in the life science industry.
More large pharma companies in India are looking to outsource product development and manufacturing to CDMOs: Hitesh Windlass, Windlas BiotechOct 06, 2021
The outsourcing market size for pharmaceutical manufacturing and development in India roughly stands at 20,000 crores and is expected to grow about 40,000 crores in next five years.
This cut in power supply has now meant that the industries operating out of such provinces will have limited ability to produce goods and operate on a more rationed basis.
Eli Lilly and Cipla enter into strategic partnership in India to enhance access to Lilly key diabetes productsOct 04, 2021
Cipla will leverage its capabilities and robust distribution strengths to engage healthcare professionals and expand access to these treatments for patients who need them.
If digitising the supply chain has become most critical, the ask is really to put in place an end-to-end solution that can help bring in operational efficiency, improve business forecasting, inventory management apart from better demand and supply planning.
Talking to Financial Express Online, Ambassador Sailas Thangal said “In November and December, the mission will be organising camps and donation drives across various regions of the country. Indian pharma companies will be part of this drive on November 13 and then another one on December 11, 2021.”
The past 18 months that forced people into social isolation and to home food and home remedies saw fewer people complaining of cold, cough and gastro-intestinal problems.
The symptoms of this disorder ranges from mild skin bleeding and bruises to potentially fatal internal bleeding, such as in the gastrointestinal tract and the brain.
Poised to grow to USD 120 to 130 billion by 2030, the pharma sector contributes significantly to India’s economic growth— 1.7 percent to the country’s GDP last year as compared to its contribution at one percent, a decade ago.
On Thursday, Biocon Biologics, a subsidiary of Biocon, had said it will offer around 15 per cent stake to Serum Institute Life Sciences (SILS), at a post-money valuation of about USD 4.9 billion.
The Hyderabad-based company said on Monday the drug would be available in the country by the end of September under the brand name Tocira.
The WCC is compulsory for exporting active pharmaceutical ingredients (APIs) to European Union (EU) countries.
Many in the pharma industry are today reminded of the days when the pandemic began unfolding early last year.